Please use this identifier to cite or link to this item:
Email to ask for this document in a different format
Title: Development of Indicators to Assess Quality of Care for Prostate Cancer.
Authors: Nag, Nupur
Millar, Jeremy
Davis, Ian D
Costello, Shaun
Duthie, James B
Mark, Stephen
Delprado, Warick
Smith, David
Pryor, David
Galvin, David
Sullivan, Frank
Murphy, Áine C
Roder, David
Elsaleh, Hany
Currow, David
White, Craig
Skala, Marketa
Moretti, Kim L
Walker, Tony
De Ieso, Paolo
Brooks, Andrew
Heathcote, Peter
Frydenberg, Mark
Thavaseelan, Jeffery
Evans, Sue M
Citation: European urology focus 2016-02-20
Abstract: The development, monitoring, and reporting of indicator measures that describe standard of care provide the gold standard for assessing quality of care and patient outcomes. Although indicator measures have been reported, little evidence of their use in measuring and benchmarking performance is available. A standard set, defining numerator, denominator, and risk adjustments, will enable global benchmarking of quality of care. To develop a set of indicators to enable assessment and reporting of quality of care for men with localised prostate cancer (PCa). Candidate indicators were identified from the literature. An international panel was invited to participate in a modified Delphi process. Teleconferences were held before and after each voting round to provide instruction and to review results. Panellists were asked to rate each proposed indicator on a Likert scale of 1-9 in a two-round iterative process. Calculations required to report on the endorsed indicators were evaluated and modified to reflect the data capture of the Prostate Cancer Outcomes Registry-Australia and New Zealand (PCOR-ANZ). A total of 97 candidate indicators were identified, of which 12 were endorsed. The set includes indicators covering pre-, intra-, and post-treatment of PCa care, within the limits of the data captured by PCOR-ANZ. The 12 endorsed quality measures enable international benchmarking on the quality of care of men with localised PCa. Reporting on these indicators enhances safety and efficacy of treatment, reduces variation in care, and can improve patient outcomes. PCa has the highest incidence of all cancers in men. Early diagnosis and relatively high survival rates mean issues of quality of care and best possible health outcomes for patients are important. This paper identifies 12 important measurable quality indicators in PCa care.
Click to open PubMed article:
Click to open Pubmed Article:
Journal title: European urology focus
Publication Date: 2016-02-20
Type: Journal Article
DOI: 10.1016/j.euf.2016.01.016
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.

Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.